Verastem Oncology (VSTM) Misses Q4 EPS by 50c

March 4, 2026 4:13 PM EST

Verastem Oncology (NASDAQ: VSTM) reported Q4 EPS of ($0.50). Revenue for the quarter came in at $17.54 million.

For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK